Acute Decompensated Heart Failure Update

Author(s): John R. Teerlink, Khalid Alburikan, Marco Metra, Jo E. Rodgers.

Journal Name: Current Cardiology Reviews

Volume 11 , Issue 1 , 2015

Submit Manuscript
Submit Proposal

Graphical Abstract:


Acute decompensated heart failure (ADHF) continues to increase in prevalence and is associated with substantial mortality and morbidity including frequent hospitalizations. The American Heart Association is predicting that more than eight million Americans will have heart failure by 2030 and that the total direct costs associated with the disease will rise from $21 billion in 2012 to $70 billion in 2030. The increase in the prevalence and cost of HF is primarily the result of shifting demographics and a growing population. Although many large, randomized, controlled clinical trials have been conducted in patients with chronic heart failure, it was not until recently that a growing number of studies began to address the management of ADHF. It is the intent of this review to update the clinician regarding the evaluation and optimal management of ADHF.

Keywords: Acute decompensated heart failure, diuretics, inotropes, vasodilators.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [53 - 62]
Pages: 10
DOI: 10.2174/1573403X09666131117174414

Article Metrics

PDF: 57